112 related articles for article (PubMed ID: 21849771)
21. Thalidomide and lenalidomide in multiple myeloma.
Mazumder A; Jagannath S
Best Pract Res Clin Haematol; 2006; 19(4):769-80. PubMed ID: 16997182
[TBL] [Abstract][Full Text] [Related]
22. Glomeruloid haemangioma with cerebriform morphology in a patient with POEMS syndrome.
Chan PT; Lee KC; Chong LY; Lo KK; Cheung YF
Clin Exp Dermatol; 2006 Nov; 31(6):775-7. PubMed ID: 17040261
[TBL] [Abstract][Full Text] [Related]
23. Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma.
van de Donk NW; Wittebol S; Minnema MC; Lokhorst HM
Br J Haematol; 2010 Jan; 148(2):335-7. PubMed ID: 20085583
[No Abstract] [Full Text] [Related]
24. Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease.
Wang X; Ye S; Xiong C; Gao J; Xiao C; Xing X
Jpn J Clin Oncol; 2011 Oct; 41(10):1221-4. PubMed ID: 21890654
[TBL] [Abstract][Full Text] [Related]
25. Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.
Yang H; Huang X; Cai Q; Wang C; Cao X; Zhou D; Li J
Orphanet J Rare Dis; 2016 Jun; 11(1):80. PubMed ID: 27317315
[TBL] [Abstract][Full Text] [Related]
26. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
Takemori N; Kondo K; Kawamura T; Imai K; Sakurai H; Sato T
Am J Hematol; 2001 Jan; 66(1):62-3. PubMed ID: 11426497
[TBL] [Abstract][Full Text] [Related]
27. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
[No Abstract] [Full Text] [Related]
28. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
[TBL] [Abstract][Full Text] [Related]
29. Class I histiocytosis: response to combination of etoposide and prednisolone.
Datta V; Mishra OP; Das BK; Kumar M; Bhargava V; Singla PN
Indian Pediatr; 1999 Jan; 36(1):83-6. PubMed ID: 10709128
[No Abstract] [Full Text] [Related]
30. POEMS syndrome: complex factors contributing to a delayed diagnosis.
Robey RC; Campus C; Ringuette B; Shumate M
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26621905
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of elderly advanced lymphomatoid granulomatosis with rituximab-CVP combination therapy.
Hu YH; Liu CY; Chiu CH; Hsiao LT
Eur J Haematol; 2007 Feb; 78(2):176-7. PubMed ID: 17313566
[No Abstract] [Full Text] [Related]
33. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
Nakayama M; Katafuchi R; Yanase T; Ikeda K; Tanaka H; Fujimi S
Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
[TBL] [Abstract][Full Text] [Related]
34. Combined proteasome and histone deacetylase inhibition: A promising synergy for patients with relapsed/refractory multiple myeloma.
Jagannath S; Dimopoulos MA; Lonial S
Leuk Res; 2010 Sep; 34(9):1111-8. PubMed ID: 20472288
[TBL] [Abstract][Full Text] [Related]
35. [A case of Wegener granulomatosis].
Zenger VG; Ashurov ZM; Golubovskiĭ GA; Mustafaev DM; Kopchenko OO; Nosova OA
Vestn Otorinolaringol; 2007; (6):60-1. PubMed ID: 18217288
[No Abstract] [Full Text] [Related]
36. Bortezomib: a new therapeutic option for POEMS syndrome.
Kaygusuz I; Tezcan H; Cetiner M; Kocakaya O; Uzay A; Bayik M
Eur J Haematol; 2010 Feb; 84(2):175-7. PubMed ID: 19732138
[TBL] [Abstract][Full Text] [Related]
37. Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma.
Tempescul A; Ianotto JC; Morel F; Marion V; De Braekeleer M; Berthou C
Ann Hematol; 2009 Sep; 88(9):921-2. PubMed ID: 19139889
[No Abstract] [Full Text] [Related]
38. Prognostic factors of diffuse proliferative lupus nephritis.
Lim CS; Chin HJ; Jung YC; Kim YS; Ahn C; Han JS; Kim S; Lee JS
Clin Nephrol; 1999 Sep; 52(3):139-47. PubMed ID: 10499308
[TBL] [Abstract][Full Text] [Related]
39. [A case of POEMS syndrome associated with Waldenström's macroglobulinemia and treated with lenalidomide].
Furuta N; Tashiro Y; Ikeda M; Fujita Y; Okamoto K
Rinsho Shinkeigaku; 2012; 52(3):186-9. PubMed ID: 22453045
[TBL] [Abstract][Full Text] [Related]
40. [Dynamic MRI of the bone marrow for monitoring multiple myeloma during treatment with thalidomide as monotherapy or in combination with CED chemotherapy].
Wasser K; Moehler T; Neben K; Nosas S; Heiss J; Goldschmidt H; Hillengass J; Düber C; Kauczor HU; Delorme S
Rofo; 2004 Sep; 176(9):1285-95. PubMed ID: 15346264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
